Greg Newby is an Assistant Professor in the McKusick-Nathans Department of Genetic Medicine and jointly affiliated with the Department of Biomedical Engineering.
His research interests include the development of efficient genome editing tools to correct genetic disease mutations as well as studying the regulatory landscape of the genome to better understand and control gene expression.
Dr. Newby earned his bachelor's degree in Biological Sciences from Carnegie Mellon University and conducted research as a Fulbright Scholar in the laboratory of Andreas Plückthun at the University of Zürich. He studied at MIT with Susan Lindquist and Ahmed Khalil for his PhD. From 2017-2023, he was a postdoctoral fellow in the laboratory of David Liu at Harvard University and the Broad Institute. During his postdoctoral work, Dr. Newby developed editing tools and methods to treat disorders of the blood, heart, lung, central nervous system, retina, liver, and skin.
He began his laboratory at JHU in 2023 in order to advance new technology that combats the suffering caused by genetic disease.